Histofy Ltd.

Histofy Ltd. is a United Kingdom company, registered in Coventry, that develops transparent artificial intelligence solutions for computational pathology. According to its official website, the company focuses on accelerating precision diagnostics in pathology workflows, with a particular emphasis on tissue-based diagnostics and prognostics. Its stated mission is to build AI that integrates with existing clinical and laboratory workflows, streamlining pathology practice and supporting personalised medicine. The company positions itself at the intersection of pathology expertise and AI engineering. Histofy says it brings together decades of experience in computational pathology, AI development and tissue image analysis, combining specialist pathology knowledge with the technical capability to build robust, validated AI products. Its tools are aimed at pathologists, biomedical researchers and the pharmaceutical industry, and are made available through integration with existing clinical workflows. Histofy's product portfolio spans both clinical diagnostics and drug development. MitPro® is an AI-driven algorithm for precise mitosis quantification and profiling, intended to increase the reliability, speed and depth of pathology analysis. The company also offers an AI-powered large bowel biopsy screening tool that removes normal slides not requiring pathologist intervention and provides triaging and decision support for abnormal slides. GI-Miner is a suite of tools for quantifying deep cellular and multi-cellular, pathologist-friendly interpretable numerical features from gastrointestinal pathology images, supporting disease profiling, patient stratification and biomarker discovery. Beagle® is an agentic AI assistant for toxicologic pathology that helps scientists interrogate complex study data, integrate findings and accelerate study report drafting. Histofy describes its technology as "transparent" and "interpretable," a positioning that distinguishes it from black-box AI approaches and is intended to build trust with pathologists and regulators. The company works with partners and collaborators across healthcare and life sciences, supporting applications from cancer diagnostics to toxicologic assessment. Its products are designed to deliver faster, more accurate and insight-driven decisions for improved patient care and more efficient drug development.

Histofy Ltd. is a United Kingdom company based in Coventry. Public information about the company's founding date and founders is limited; its Wikidata entry describes it simply as a company in Coventry, United Kingdom. The company operates in the field of computational pathology, applying artificial intelligence to digital pathology images. Histofy's public materials emphasise that it was built on deep expertise in AI for pathology, bringing together experience in computational pathology, AI development and tissue image analysis. The company states that its team combines specialist knowledge of pathology with the technical expertise needed to develop robust, high-performing AI products, and that it focuses on solutions that are rigorously validated, practical to deploy and designed to deliver meaningful value for partners and customers. Histofy has developed a portfolio of AI products and services for cellular pathology. MitPro® is its next-generation mitosis profiling algorithm, designed for precise mitosis quantification and profiling to increase the reliability, speed and depth of pathology analysis. The company also offers an AI-powered large bowel biopsy screening tool that streamlines clinical workflows by removing normal slides that do not require further intervention from pathologists, and provides triaging and decision support for slides flagged as abnormal. GI-Miner is a suite of tools for quantification of deep cellular and multi-cellular, pathologist-friendly interpretable numerical features from gastrointestinal pathology images. It leverages state-of-the-art machine learning models to identify important cells and key histological structures, transforming complex pathology image data into rich, measurable attributes — described by the company as Measurable Attributes for Pathology (MAPs) — designed for advancing biopharma research, patient stratification and biomarker discovery. Beagle® is an agentic AI assistant for toxicologic pathology. Named after Charles Darwin's HMS Beagle, it is designed to help toxicologic pathologists and scientists interrogate complex study data, integrate findings with insights from internal and external sources, and accelerate study report drafting and decision-making. The product imports raw study data from LIMS, SEND datasets or Excel, or connects directly to a laboratory information system (LIS); its reasoning engine analyses findings and drafts the complete report narrative; and the study director reviews, edits and exports the final report as a PDF or Word document. Histofy states that its AI services are currently made available through integration with existing clinical workflows, and that it develops AI solutions for pathology to advance both clinical care and drug development, from cancer diagnostics to toxicologic assessment. The company works with partners and collaborators across healthcare and life sciences.

Transparent, interpretable AI for computational pathology, integrating with existing clinical and laboratory workflows to support precision diagnostics and drug development.

• MitPro®

  AI-driven algorithm for precise mitosis quantification and profiling, offering enhanced pathology workflows by increasing the reliability, speed and depth of analysis.

• AI-powered large bowel biopsy screening

  AI-powered colon biopsy screening tool that streamlines clinical workflows by removing normal slides that do not require further intervention from pathologists; for slides flagged as abnormal, it offers triaging and decision support.

• GI-Miner

  A suite of tools for quantification of deep cellular and multi-cellular pathologist-friendly interpretable numerical features from gastrointestinal (GI) pathology images, supporting precise disease profiling, patient stratification and biomarker discovery.

• Beagle®

  An agentic AI assistant that empowers toxicologic scientists to interrogate complex study data, integrate findings with insights from internal/external sources, and accelerate study report drafting and decision-making.

1. 1Histofy: Transparent AI for Pathology & Diagnosticshistofy.ai
2. 2AI Pathology Solutions | MitPro®, GI-Miner & Beaglehistofy.ai
3. 3Beagle: Accelerate Tox Study Reporting | Histofy AIhistofy.ai
4. 4GI-Miner: Deep Profiling of GI Tissue | Histofyhistofy.ai
5. 5Histofy Ltd. (United Kingdom) - Wikidatawikidata.org